The NEUROD1-driven subtype (SCLC-N) typically shows lower neuroendocrine marker expression, whereas the POU2F3-defined subset (SCLC-P) is largely without classical neuroendocrine markers. Here, NEUROD1 is linked to small cell lung carcinoma.